| Authors: |
Hudson G; Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, UK., Uphill J; MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Hummerich H; MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Blevins J; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Gambetti P; Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Zerr I; Clinical Dementia Center, Department of Neurology, Georg-August University Göttingen, Göttingen, Germany; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich Munich, Germany., Collinge J; MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK., Mead S; MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. Electronic address: s.mead@prion.ucl.ac.uk., Chinnery PF; Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, UK. |